Due Diligence and Art

Due Diligence and Art

Selling Tools to Utter Tools: The scam of "gene editing".

"Gene editing’s search for a ‘holy grail’ has led to an explosion of tools, but few cures" - Endpoints News

Sasha Latypova's avatar
Sasha Latypova
Jan 30, 2026
∙ Paid

Endpoints News is a subsidiary of the Financial Times, focusing on pharma industry news. Of course, they are Big Pharma promoters and there isn’t a toxic & useless drug or injection out there that they don’t like. However, in the past few months I was shocked to see that even these pharma marketers are beginning to realize that “gene editing” (as in g…

User's avatar

Continue reading this post for free, courtesy of Sasha Latypova.

Or purchase a paid subscription.
© 2026 Sasha Latypova · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture